MedTrace Logo

Considerations on the Transfusion Threshold in Cardiac Surgery

NCT03346512 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 852

Last updated 2019-04-19

No results posted yet for this study

Summary

This is a retrospective observational study of the transfusion threshold in cardiac surgery.

There is controversy in the literature regarding the transfusion threshold to be adopted, especially in a patient who has undergone cardiac surgery. Some authors suggest that the transfusion should be done in a restrictive way when a certain threshold in hemoglobin is reached, in order to avoid the risks it implies, especially infectious.This threshold is very controversial and remains to be defined (variations in the literature from 7g / dL to 9g / dL). Other authors conclude that there is no superiority of a restrictive transfusion compared to a more liberal transfusion, with regard to the morbidity or medical costs.

It is therefore interesting to study, in a retrospective manner, the global and multidisciplinary management of patients who have undergone a cardiac surgery within the CHU Brugmann hospital, to analyze if they have been adequately transfused.

Conditions

  • Cardiac Surgery

Interventions

PROCEDURE

Cardiac surgery

Cardiac surgery

Sponsors & Collaborators

  • Pierre Wauthy

    lead OTHER

Principal Investigators

  • Kenza Bradly, MD · CHU Brugmann

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-02-29
Primary Completion
2016-06-14
Completion
2016-06-14

Countries

  • Belgium

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03346512 on ClinicalTrials.gov